PFIZER INC

Pharmaceutical Preparations·NEW YORK, NY·FY end 12/31·CIK 78003

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
A. BourlaChairman and Chief Executive Officer	$1.8M	$9.4M	$9.0M	$5.4M	$1.9M	$27.6M
C. BoshoffChief Scientific Officer and President, Research & Development	$1.4M	$1.8M	$3.0M	$3.1M	$648.0K	$10.0M
D. DentonChief Financial Officer, EVP	$1.4M	$2.4M	$2.5M	$2.8M	$613.8K	$9.7M
A. MalikChief U.S. Commercial Officer, EVP	$1.4M	$2.3M	$2.2M	$2.9M	$611.2K	$9.4M
D. LanklerChief Legal Officer, EVP	$1.4M	$2.0M	$2.2M	$2.7M	$793.6K	$9.1M

A. Bourla · FY 2025

Stock awards$9.4M34%

Performance bonus$5.4M20%

Salary$1.8M7%

Other$10.9M40%

TSR % vs. CEO comp actually paid · 5 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY21

+67%

$115M

FY22

+49%

$6M

FY23

-12%

$-62M

FY24

-14%

$39M

FY25

-14%

$34M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.